Tosoh (4042) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Sep, 2025Executive summary
Net sales for 1Q–3Q FY2025 rose to ¥795.7B, up 6.4% year-over-year, driven by higher sales volumes, a weaker yen, and increased naphtha prices.
Operating income increased by 25.3% to ¥74.6B, ordinary income reached ¥82.5B, and profit attributable to owners of parent was ¥48.5B, all up year-over-year.
All major business segments except 'Other' posted higher sales and operating income, with notable gains in Petrochemical and Chlor-alkali.
Global economic conditions remained stable, but uncertainties persist due to weak demand in China and policy concerns in the US.
Financial highlights
Capital expenditures increased by ¥20.9B to ¥65.2B; interest-bearing liabilities rose by ¥16.8B to ¥211.1B.
Gross profit increased to ¥192.8B from ¥167.2B year-over-year; basic earnings per share rose to ¥152.37 from ¥129.95.
Total assets reached ¥1,325.4B, net assets increased to ¥880.6B, and equity ratio improved to 61.3%.
Cash and cash equivalents at end of period decreased by ¥7.2B to ¥128.0B; free cash flow turned negative at -¥16.9B due to higher investing cash outflows.
Outlook and guidance
FY2025 net sales forecast at ¥1,070.0B, down from previous forecast; operating income forecast raised to ¥98.0B, and net profit at ¥61.0B.
Basic earnings per share forecast raised to ¥191.55; dividend forecast increased to ¥100 per share, payout ratio projected at 52.2%.
Ordinary income and profit attributable to owners of parent expected to surpass previous forecasts due to strong water treatment and FX gains.
Sales volumes expected to decline amid weak Chinese economy and slow semiconductor recovery.
Latest events from Tosoh
- Profits fell sharply on lower sales and a major impairment loss, despite engineering growth.4042
Q3 20265 Feb 2026 - Lower sales and a major impairment loss led to a sharp drop in net income despite segment growth.4042
Q2 20264 Nov 2025 - Profits fell on weaker petrochemical and chlor-alkali results, but guidance is unchanged.4042
Q1 20265 Aug 2025 - Sales and profits rose on higher prices and FX gains; outlook and dividend unchanged.4042
Q1 202513 Jun 2025 - Sales and operating income surged, but net profit fell amid forex losses and market uncertainty.4042
Q2 202513 Jun 2025 - Operating and net sales rose, with strong segment growth and robust future profit guidance.4042
Q4 20256 Jun 2025